According to the Midwest Health Care Venture Investment Report, released by BioEnterprise, Cleveland area biotech firms raised $83 million in venture capital the first half of 2012.

Juventas Therapeutics, developer of a pipeline of regenerative therapies to treat life threatening diseases, secured $22 million alone. Pharmaceutical developer Athersys raised $9 million.

Read the entire report here.